A detailed history of Wilkins Investment Counsel Inc transactions in Pfizer Inc stock. As of the latest transaction made, Wilkins Investment Counsel Inc holds 263,934 shares of PFE stock, worth $7.06 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares
263,934
Previous 261,234 1.03%
Holding current value
$7.06 Million
Previous $7.31 Million 4.5%
% of portfolio
1.07%
Previous 1.1%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$27.7 - $31.39 $74,790 - $84,753
2,700 Added 1.03%
263,934 $7.64 Million
Q2 2024

Aug 08, 2024

BUY
$25.26 - $29.6 $105,662 - $123,816
4,183 Added 1.63%
261,234 $7.31 Million
Q1 2024

May 09, 2024

BUY
$25.89 - $29.73 $3.98 Million - $4.58 Million
153,890 Added 149.17%
257,051 $7.13 Million
Q4 2023

Feb 12, 2024

BUY
$26.13 - $33.94 $26,130 - $33,940
1,000 Added 0.98%
103,161 $2.97 Million
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $22,077 - $25,806
-688 Reduced 0.67%
102,161 $3.39 Million
Q2 2023

Aug 07, 2023

SELL
$36.12 - $41.79 $267,288 - $309,246
-7,400 Reduced 6.71%
102,849 $3.77 Million
Q1 2023

May 08, 2023

BUY
$39.39 - $51.28 $23,634 - $30,768
600 Added 0.55%
110,249 $4.5 Million
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $13,151 - $17,167
-315 Reduced 0.29%
109,649 $5.62 Million
Q2 2022

Aug 08, 2022

SELL
$46.53 - $55.17 $116,325 - $137,925
-2,500 Reduced 2.22%
109,964 $5.77 Million
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $59,795 - $74,093
-1,307 Reduced 1.15%
112,464 $5.82 Million
Q4 2021

Feb 10, 2022

SELL
$41.32 - $61.25 $41,320 - $61,250
-1,000 Reduced 0.87%
113,771 $6.72 Million
Q2 2021

Jul 30, 2021

SELL
$35.91 - $40.68 $21,545 - $24,408
-600 Reduced 0.52%
114,771 $4.49 Million
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $127,262 - $143,526
-3,800 Reduced 3.19%
115,371 $4.18 Million
Q4 2020

Feb 09, 2021

SELL
$33.47 - $42.56 $83,675 - $106,400
-2,500 Reduced 2.05%
119,171 $4.39 Million
Q2 2020

Aug 10, 2020

SELL
$30.12 - $36.54 $12,048 - $14,616
-400 Reduced 0.33%
121,671 $3.98 Million
Q1 2020

May 11, 2020

SELL
$27.03 - $38.62 $57,276 - $81,835
-2,119 Reduced 1.71%
122,071 $3.98 Million
Q3 2019

Nov 08, 2019

BUY
$32.49 - $42.13 $25,992 - $33,704
800 Added 0.65%
124,190 $4.46 Million
Q2 2019

Aug 09, 2019

SELL
$36.98 - $41.52 $103,543 - $116,256
-2,800 Reduced 2.22%
123,390 $5.35 Million
Q1 2019

May 10, 2019

SELL
$37.5 - $41.2 $187,500 - $206,000
-5,000 Reduced 3.81%
126,190 $5.36 Million
Q4 2018

Feb 11, 2019

SELL
$38.47 - $43.86 $3,847 - $4,386
-100 Reduced 0.08%
131,190 $5.73 Million
Q3 2018

Nov 09, 2018

SELL
$34.47 - $41.81 $99,963 - $121,249
-2,900 Reduced 2.16%
131,290 $5.79 Million
Q2 2018

Aug 09, 2018

SELL
$32.98 - $35.16 $1.81 Million - $1.93 Million
-55,022 Reduced 29.08%
134,190 $4.87 Million
Q1 2018

May 09, 2018

SELL
$31.91 - $37.02 $2.39 Million - $2.77 Million
-74,902 Reduced 28.36%
189,212 $6.72 Million
Q4 2017

Feb 09, 2018

SELL
$33.26 - $35.29 $263,685 - $279,779
-7,928 Reduced 2.91%
264,114 $9.57 Million
Q3 2017

Nov 13, 2017

SELL
$31.0 - $34.15 $10,912 - $12,020
-352 Reduced 0.13%
272,042 $9.71 Million
Q2 2017

Aug 10, 2017

BUY
N/A
272,394
272,394 $9.15 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Wilkins Investment Counsel Inc Portfolio

Follow Wilkins Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilkins Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wilkins Investment Counsel Inc with notifications on news.